Imiquimod (Aldara)

Catalog No. A10469

Imiquimod (Aldara) is a a heterocyclic imidazoquinoline amide that acts as an immune response modifier.

Product Citations

Kunishita Y, .et al. TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis, Front Immunol, 2020, Feb 7;11:98 PMID: 32117252

Technical details

Catalog Num	A10469
M. Wt	240.3
Formula	C14H16N4
Purity	>98%
Storage	at -20°C 3 years Powder
CAS No.	99011-02-6
Synonyms	Aldara
SMILES	CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N

Biological Activity

Imiquimod (Aldara) is a a heterocyclic imidazoquinoline amide that acts as an immune response modifier.

Targets

Solubility *

In vitro	DMSO	0.01 mg/mL (<1 mM)
	Water	<1 mg/mL (<1 mM)
	Ethanol	<1 mg/mL (<1 mM)
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Preparing Stock Solutions

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.1 mM	41.61 mL	208.07 mL	416.15 mL
0.5 mM	8.32 mL	41.61 mL	83.23 mL
1 mM	4.16 mL	20.81 mL	41.61 mL
5 mM	0.83 mL	4.16 mL	8.32 mL

*The above data is based on the productmolecular weight 240.3 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Adooq Bioscience